CareDx, Inc (NASDAQ:CDNA – Get Free Report) was the target of a significant drop in short interest in July. As of July 31st, there was short interest totalling 3,480,000 shares, a drop of 11.2% from the July 15th total of 3,920,000 shares. Based on an average trading volume of 917,000 shares, the short-interest ratio is presently 3.8 days. Currently, 7.1% of the company’s stock are short sold.
Institutional Trading of CareDx
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CDNA. Caxton Associates LP boosted its position in shares of CareDx by 97.2% in the first quarter. Caxton Associates LP now owns 96,308 shares of the company’s stock valued at $1,020,000 after acquiring an additional 47,469 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its holdings in CareDx by 87.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 228,198 shares of the company’s stock valued at $2,417,000 after purchasing an additional 106,660 shares during the period. Los Angeles Capital Management LLC grew its position in CareDx by 138.9% in the 4th quarter. Los Angeles Capital Management LLC now owns 237,115 shares of the company’s stock worth $2,845,000 after purchasing an additional 137,842 shares during the last quarter. Bamco Inc. NY acquired a new stake in CareDx in the 1st quarter worth $13,025,000. Finally, Vanguard Group Inc. increased its holdings in shares of CareDx by 4.4% during the 1st quarter. Vanguard Group Inc. now owns 4,300,016 shares of the company’s stock worth $45,537,000 after purchasing an additional 180,334 shares during the period.
CareDx Stock Performance
Shares of CareDx stock traded up $4.65 during trading on Friday, reaching $33.00. The company’s stock had a trading volume of 2,551,122 shares, compared to its average volume of 915,056. CareDx has a one year low of $4.80 and a one year high of $33.13. The firm has a market cap of $1.72 billion, a price-to-earnings ratio of -9.65 and a beta of 1.78. The business’s fifty day moving average price is $18.54 and its 200-day moving average price is $13.41.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on CDNA
About CareDx
CareDx, Inc engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients.
Further Reading
- Five stocks we like better than CareDx
- What is the Hang Seng index?
- This Small Cap Wealth Management Stock Could Provide Big Returns
- What are earnings reports?
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Most active stocks: Dollar volume vs share volume
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for CareDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareDx and related companies with MarketBeat.com's FREE daily email newsletter.